drugset / Trial / NCT01296542

A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery

NCT01296542

Phase 4 Completed 60 enrolled Bucci Laser Vision Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare antibacterial efficacy of Besivance versus VIGAMOX for decreasing bacteria of the conjunctiva and lid margins in cataract patients prior to surgery after both 1 hour and 3 days of treatment.

Timeline

Start
2011-05
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Besifloxacin Small molecule Other
Comparator Moxifloxacin Small molecule Other

Indications